Submitted for Publication: May 25, 2012; final revision received February 13, 2013; accepted February 16, 2013.
Published Online: September 4, 2013. doi:10.1001/jamapsychiatry.2013.1909.
Acquisition of data: Carrión, McLaughlin, Auther, Olsen, Cornblatt.
Analysis and interpretation of data: Carrión, Goldberg, Olvet, Correll, Cornblatt.
Drafting of the manuscript: Carrión, Olvet, Cornblatt.
Critical revision of the manuscript for important intellectual content: Carrión, McLaughlin, Goldberg, Auther, Olsen, Correll, Cornblatt.
Statistical analysis: Carrión, Goldberg, Olvet.
Administrative, technical, or material support: McLaughlin, Auther, Olsen, Cornblatt.
Study supervision: Correll, Cornblatt.
Conflict of Interest Disclosures: Dr Cornblatt was the original developer of the Continuous Performance Test, Identical Pairs version and has been an advisor for Merck. Dr Goldberg has received consulting fees from Merck and GlaxoSmithKline within the past year. He receives royalties for use of the Brief Assessment of Cognition in Schizophrenia in clinical trials. Dr Correll has been a consultant and/or advisor to or has received honoraria from Actelion, Alexza, American Academy of Child and Adolescent Psychiatry, AstraZeneca, Biotis, Bristol-Myers Squibb, Cephalon, Desitin, Eli Lilly, Gerson Lehrman Group, GlaxoSmithKline, IntraCellular Therapies, Lundbeck, MedAvante, Medscape, Merck, National Institute of Mental Health, Novartis, Ortho-McNeil/Janssen/Johnson & Johnson, Otsuka, Pfizer, ProPhase, Sunovion, Takeda, and Teva. He has received grant support from Bristol-Myers Squibb, Feinstein Institute for Medical Research, Janssen/Johnson & Johnson, National Institute of Mental Health, National Alliance for Research in Schizophrenia and Depression, and Otsuka. No other disclosures were reported.
Funding/Support: This work was supported by grants MH61523-02 and MH61523-8 from the National Institute of Mental Health (Dr Cornblatt) and Zucker Hillside Hospital National Institute of Mental Health Advanced Center for Intervention and Services Research for the Study of Schizophrenia grant MH 074543-01 (John M. Kane, MD).
Additional Contributions: We thank the study participants and entire staff of the RAP Program for their time and effort from the very onset of these studies. In particular, we thank Rita C. Barsky, PhD, Kristin A. Candan, PhD, Pradeep Nagachandran, MD, and Stephanie Snyder, PsyD, for assistance in carrying out this study.